Fluconazole–excipient compatibility studies as the first step in the development of a formulation candidate for biowaiver
Crossref DOI link: https://doi.org/10.1007/s10973-014-4316-z
Published Online: 2014-12-24
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Teleginski, Lilian Klein
Maciel, Aline Biggi
Mendes, Cassiana
Silva, Marcos Antônio Segatto
Bernardi, Larissa Sakis
de Oliveira, Paulo Renato
Text and Data Mining valid from 2014-12-24